🇺🇸 FDA
Patent

US 11427571

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

granted A61KA61K9/20A61P

Quick answer

US patent 11427571 (Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production) held by DENALI THERAPEUTICS INC. expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K9/20, A61P, A61P25/28